Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Pr
-
最新报道：Immuneering Corporation has priced its public offering of 18.96 million Class A common shares at $9.23 per share, matching its Nasdaq closing price on September 24, 2025. The offering includes an underwriter option for an additional 2.84 million shares and is expected to generate approximately $175 million in gross proceeds. Concurrently, Sanofi will purchase 2.71 million shares in a private placement at the same price. Both transactions are set to close around September 26, 2025, with proceeds funding preclinical/clinical development and general corporate purposes. Leerink Partners and Oppenheimer & Co. are serving as joint bookrunners.
下一篇
Building bridges between China and Egypt
- Mohamed Jihad, an Egyptian graduate from China's Communication University, has become a cu...
24小时热点
热点专题
411717